Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ELF2 pseudogene 3 (ELF2P3) is annotated as a pseudogene of the ELF2 (E74 Like ETS Transcription Factor 2) gene. Pseudogenes are genomic sequences similar to known genes but considered nonfunctional as they generally do not encode functional proteins[3][4]. While some pseudogenes can have regulatory roles at the RNA level—such as acting as competitive endogenous RNAs (ceRNAs)[4]—there is no specific evidence that ELF2P3 plays such a role. The parental gene, ELF2, encodes a transcription factor involved in cell cycle progression and immune cell regulation[2][5], but ELF2P3 itself is not considered a therapeutic target, does not code for a protein, and has not been associated with pharmacologically relevant functions or disease roles. Due to its annotation as a pseudogene and absence from target databases or drug discovery literature, ELF2P3 is not regarded as a receptor, enzyme, transporter, or other target class protein.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ELF2 pseudogene 3 (ELF2P3).